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Abstract 
Purpose: Radiomic features have demonstrated promise in improving tumor classification, 
treatment outcome prediction, and survival analysis. However, most existing radiomic studies 
were based on features extracted using manual contours. Large inter-observer segmentation 
variations may lead to inconsistent features and introduce additional challenges in constructing 
robust prediction models. Here, we proposed a fully automatic workflow for glioblastoma (GBM) 
survival prediction using deep learning (DL) methods.  
Methods: 285 glioma (210 GBM, 75 low-grade glioma) patients were included. 163 of the GBM 
patients had overall survival (OS) data. Every patient had four pre-operative MR scans and 
manually drawn tumor contours. For automatic tumor segmentation, a 3D convolutional neural 
network (CNN) was trained and validated using 122 glioma patients. The trained model was 
applied to the remaining 163 GBM patients to generate tumor contours. The handcrafted and DL-
based radiomic features were extracted from auto-contours using explicitly designed algorithms 
and a pre-trained CNN respectively. 163 GBM patients were randomly split into training (n=122) 
and testing (n=41) sets for survival analysis. Cox regression models with regularization techniques 
were trained to construct the handcrafted and DL-based signatures. The prognostic power of the 
two signatures was evaluated and compared.  
Results:  The 3D CNN achieved an average Dice coefficient of 0.85 across 163 GBM patients for 
tumor segmentation. The handcrafted signature achieved a C-index of 0.64 (95% CI: 0.55-0.73), 
while the DL-based signature achieved a C-index of 0.67 (95% CI: 0.57-0.77). Unlike the 
handcrafted signature, the DL-based signature successfully stratified testing patients into two 
prognostically distinct groups (p-value<0.01, HR=2.80, 95% CI: 1.26-6.24).  
Conclusions:  The proposed 3D CNN generated accurate GBM tumor contours from four MR 
images. The DL-based signature resulted in better GBM survival prediction, in terms of higher C-
index and significant patient stratification, than the handcrafted signature. The proposed automatic 
radiomic workflow demonstrated the potential of improving patient stratification and survival 
prediction in GBM patients. 
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1. Introduction 
Glioma is the most common type of primary brain tumor in adults. It arises from glial cells, 
normally astrocytes and oligodendrocytes. According to the World Health Organization guideline1, 
glioma can be classified into grade I to IV based on the histological characteristics. Glioblastoma 
multiforme (GBM) is the most aggressive, grade IV, glioma. It accounts for 81% of malignant 
brain tumors2. Despite extensive efforts, GBM patient prognoses remain dismal. The median 
overall survival (OS) is 14 to 16 months after diagnosis3. The 5-year survival rate is below 5%4. It 
is beneficial to build survival prediction models for assisting therapeutic decisions and disease 
management in GBM patients.  
 Magnetic resonance imaging (MRI) is the preferred imaging modality for GBM diagnosis 
and monitoring. Radiomic features extracted from MR images using advanced mathematical 
algorithms may uncover tumor characteristics that fail to be appreciated by the naked eye. Recent 
studies demonstrated that these features can assist in tumor grading and predict the isocitrate 
dehydrogenase (IDH) genotype for glioma patients5,6. Many studies have investigated the 
association of radiomic features with the survival outcomes of GBM patients. Most of them were 
based on radiomic features extracted using explicitly designed, or “handcrafted”, algorithms7,8. 
These handcrafted features are normally low-level image features that are limited to current human 
knowledge. 
 Another type of radiomic feature is extracted using deep learning (DL) methods like 
convolutional neural networks (CNNs)9, 10. These high-level features may have higher prognostic 
power than the handcrafted features. A study demonstrated that DL-based radiomic features 
extracted via transfer learning achieved promising performance in GBM survival prediction11. 
However, the radiomic features were extracted from manual tumor contours in this study.  Manual 
tumor segmentation is not only time consuming but also sensitive to intra-observer and inter-
observer variabilities. Studies have shown that inter-observer contour variation could result in 
many inconsistent radiomic features12, 13. This may introduce additional challenges in constructing 
robust prediction models. Developing an automatic GBM tumor segmentation model could erase 
this concern.  
 In this study, we proposed an automatic workflow for achieving GBM survival prediction 
using four pre-operative MR images. A 3D CNN was proposed and trained for automatically 
generating GBM tumor contours. We investigated whether radiomic features extracted using the 
auto-contours were associated with GBM OS. The handcrafted and DL-based radiomic features 
were extracted from the auto-contours and used to construct two separate Cox regression models. 
The prognostic power of the constructed signatures was evaluated and compared for better model 
performance. 
 
2. Materials and methods 
2.1. Dataset 
285 glioma patients were acquired from the BRaTS2018 challenge14–16. 210 patients had GBM, 
and the remaining 75 patients had low-grade (grade II-III) glioma (LGG). Each patient had four 
MR images acquired. These included T1-weighted (T1w), contrast-enhanced T1-weighted (CE-
T1w), T2-weighted (T2w), and fluid-attenuated inversion recovery (FLAIR) MR images. Patient 
images were acquired with different clinical protocols and various scanners from multiple 
institutions. For each patient, MR images were co-registered, resampled to 1 mm3 resolution, and 
skull-stripped. The final image dimension was 240×240×155. All patients have three ground truth 
tumor subregion labels (edema, enhancing tumor core, and non-enhancing tumor core) approved 
by experienced neuro-radiologists. OS data was available for 163 GBM patients. 
 We applied N4 bias correction17 on all images, except the FLAIR images, to remove low-
frequency inhomogeneity. Each MR image was normalized to have zero mean and unit standard 
deviation in the brain voxels. Figure 1 shows the transverse slice of four preprocessed MR images 
and the corresponding tumor labels.  
 
Figure 1. Transverse slices of preprocessed T1w, CE-T1w, T2w, FLAIR images along with the 
corresponding ground truth labels for edema, enhancing tumor core, and non-enhancing tumor core for a 
representative case.  
 
2.2. 3D CNN for tumor segmentation 
Figure 2 shows the architecture of the 3D CNN proposed for tumor segmentation. It contains 27 
convolutional layers, forming an encoder and decoder architecture. Instance normalization layers18 
and residual shortcuts19 are implemented to improve model performance. The proposed 3D CNN 
can be trained to perform an end-to-end mapping, converting the concatenation of four 
preprocessed images to four probability maps for three tumor subregion labels and background 
labels.  
 Figure 2. The overall 3D CNN architecture. Four MR images are concatenated and input into the 3D CNN 
containing 27 convolutional layers. The model generates four probability maps. Each filled box represents 
a set of 4D feature maps, the numbers and dimensions of which are shown. The window size and the stride 
for convolutional, maxpooling, and deconvolutional layers are also presented. Conv, convolutional layer; 
IN, instance normalization layer; ReLu, rectified linear unit; Maxpool, maxpooling layer; Deconv, 
deconvolutional layer. 
 In the model training stage, 122 patients without OS data were randomly split into a training 
set of 105 patients (75 LGG patients and 30 GBM patients) and a validation set of 17 GBM 
patients. The validation set was used for tuning hyperparameters including the stopping epoch 
number and the learning rate. The Adam stochastic gradient descent method20 was used to 
minimize the multi-Dice loss,  
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(1) 
where Pij is the probability, after Softmax layers, of the voxel j being the label i; Lij is the ground 
truth label, 0 or 1, of the voxel j being the label i; N is the voxel number. 
 The 3D CNN was trained using the training set with a batch size of 1 for 50 epochs. These 
hyperparameters were determined using the validation set. The trained network was applied to the 
remaining 163 GBM patients (all of which have corresponding OS data) to generate their tumor 
subregion labels. The tumor contour was acquired by merging the three subregion labels. Model 
accuracy was evaluated using the Dice coefficient, 
Dice =
2(Vground ∩ Vpred  )
Vground +  Vpred 
, 
(2) 
where Vground and Vpred are the ground truth tumor contour and 3D CNN predicted tumor contour, 
respectively. 
 
2.3. Radiomic feature extraction 
2.3.1. Handcrafted features 
1106 handcrafted features were extracted from four MR images using the PyRadiomics21 package 
(version 2.1.2) for all 163 GBM patients. These features were extracted from the 3D CNN-
predicted tumor contour and contained 14 shape-based features, 72 first-order statistical features, 
292 second-order statistical (textural) features, and 728 high-order statistical features. Shape-based 
features represented the shape characteristics of the tumor contour. First-order statistical features 
represented the characteristics of the tumor intensity distribution. Textural features were extracted 
based on gray level co-occurrence, gray level size zone, gray level run length, gray level 
dependence, and neighborhood gray-tone difference matrices. They represented the characteristics 
of the spatial intensity distributions. High-order statistic features were extracted from the images 
filtered using Laplacian of Gaussian (LoG) filters.  
 
2.3.2. DL-based features  
1472 DL-based features were extracted using a pre-trained classification CNN, VGG1922, for all 
163 GBM patients in the testing set.  Figure 3 shows the model architecture and feature extraction 
scheme. VGG19 contains 16 convolutional layers and 3 fully-connected layers. 5 max-pooling 
layers are used to achieve partial translational invariance, reduce model memory usage, and 
prevent overfitting. For each patient, we selected a square region of interest (ROI) from the 
transverse slice that had the largest 3D CNN-predicted tumor contour area. The dimension of the 
ROI was set as the maximum dimension of the tumor contour on the selected slice. We then 
extrapolated the ROIs of FLAIR, T2w, and CE-T1w MR images to 224×224, mapped the pixel 
intensity to the range [0, 255], and concatenated them. The concatenation was input into the pre-
trained VGG19 for feature extraction. As shown in Figure 3, DL-based features were extracted by 
average-pooling the 5 feature maps after max-pooling layers. Each feature map generated a vector 
after average-pooling. Five feature vectors were first normalized with their Euclidean norms and 
then concatenated to form a single feature vector. DL-based features were acquired by normalizing 
the single feature vector with its Euclidean norm.  
Figure 3. DL-based feature extraction scheme using VGG19. VGG19 contains 16 convolutional layers, 5 
max-pooling layers, and 3 fully-connected layers. The average-pooling layers were used for extracting DL-
based features. Feature maps and feature vectors after every layer are shown as cuboids and rectangles, 
respectively. The feature map depth and feature number are shown. A concatenation of FLAIR, T2w, and 
CE-T1w ROIs was input into the pre-trained VGG19 for feature extraction. 1472 DL-based features were 
extracted from max-pooling feature maps by average-pooling along the spatial dimensions. Conv, 
convolutional layer; ReLu, rectified linear unit. 
 
2.4. Survival prediction model 
The 163 GBM patients with available OS data were randomly split into a training set of 122 
patients and a testing set of 41 patients. Each feature was normalized using the mean and standard 
deviation of the training set. Since a large number of features may lead to overfitting, we pre-
selected a subset of features having the highest univariate C-index. Higher C-index values indicate 
features with higher prognostic power. The Cox regression model with regularization was trained 
using the selected features to construct a radiomic signature for survival prediction in GBM 
patients. The radiomic signature is a linear combination of the features weighted by the Cox 
regression model coefficients. We tested three regularization techniques: Ridge, Elastic Net, and 
Least Absolute Shrinkage and Selection Operator (LASSO).  The number of the pre-selected 
features, the regularization technique, and the corresponding regularization parameters were 
chosen with 5-fold cross-validation using the training set. Two Cox regression models were trained 
using either handcrafted features or DL-based features. The resulting radiomic signatures are 
referred to as the handcrafted signature and the DL-based signature, respectively. The prognostic 
power of the two constructed radiomic signatures was compared using the C-index and the average 
areas under the receiver operating curves (AUCs) at different survival time points on the testing 
set. Paired t-tests and DeLong tests were conducted to test the significance of the differences in C-
index and receiver operating curves, respectively. A threshold on the radiomic signature can be set 
using the training set for patient stratification. We investigated two thresholds: one selected using 
the X-tile software23, and the other defined by the median signature value of the training patients. 
The X-tile software selected the optimal threshold by selecting the highest 𝑋2 value of the data 
divisions. The chosen thresholds were then used to stratify the testing patients into high-risk and 
low-risk groups. Log-rank tests were conducted to test the difference between the two risk groups 
for significance. 
 
3. Results 
3.1. OS statistics 
The median and mean of OS were 367.0 days and 416.5 days in the training set, and 362.0 days 
and 442.1 days in the testing set, respectively. A Mann-Whitney U test indicated that there was no 
significant difference in OS between two datasets (p-value=0.83). 
 
3.2.Tumor segmentation 
Figure 4 compares the ground truth segmentation and 3D CNN predicted tumor contour for three 
patients in the testing set. Contours generated by the trained 3D CNN were smoother than the 
corresponding ground truth contours. They had similar shapes based on visual inspection. 
The Dice coefficients of tumor contours for the training, validation, and testing sets are 
summarized in Table 1. The predicted contours achieved the Dice coefficient of 0.85±0.09 for 163 
GBM patients in the testing set.  
 
Figure 4. Ground truth contour (top) and 3D predicted contour (bottom) for 3 GBM patients 
 
 Training 
(75 LGG and 30 GBM) 
Validation 
(17 GBM) 
Testing 
(163 GBM) 
Dice 0.91±0.03 0.90±0.06 0.85±0.09 
Table 1. Dice coefficients of the tumor contour for the training, validation, and testing sets. Results were 
averaged and showed in (mean ± SD) format. 
 
3.3. Survival prediction  
The handcrafted signature achieved a C-index of 0.64 (95% confidence intervals [CI]: 0.55-0.73) 
on the testing set, while the DL-based signature achieved a C-index of 0.67 (95% CI: 0.57-0.77). 
A paired t-test showed that there was no significant difference in these C-indexes (p-value=0.27).  
 Table 2 shows the AUCs of the signatures evaluated at three survival time points (183, 356, 
and 548 days) on the testing set.  The handcrafted signature achieved higher AUCs evaluated at 
the OS of 183 days and 365 days, while the DL-based signature achieved higher AUC evaluated 
at 548 days. p-values of DeLong tests indicated that there was no significant difference in all AUC 
results.  
Relapse time 
(days) 
Handcrafted 
 
DL-based p-value 
183 0.76 (0.60-0.92) 0.75 (0.57-0.93) 0.93 
365 0.77 (0.62-0.92) 0.74 (0.58-0.90) 0.72 
548 0.58 (0.37-0.79) 0.68 (0.50-0.86) 0.26 
Table 2. AUC results, evaluated at three survival time points, for the handcrafted and DL-based signatures. 
95% confidence intervals are shown in the parentheses. p-values of the corresponding DeLong tests are 
shown in the last column.   
 The testing patients were split into high-risk and low-risk groups based on signature 
thresholds. Figure 5 shows the Kaplan-Meier survival curves of the two risk groups. There was no 
significant association between the risk groups, stratified by thresholding the handcrafted 
signature, and the patient OS. (X-tile: p-value=0.31, hazard ratio [HR]=1.44, 95% CI: 0.71-2.91; 
Median: p-value=0.20, HR=1.51, 95% CI: 0.80-2.87). On the other hand, thresholds on the DL-
based signature resulted in significant stratification of patients into two prognostically distinct 
groups (X-tile: p-value<0.01, HR=2.80, 95% CI: 1.26-6.24; Median: p-value=0.02, HR=2.16, 95% 
CI: 1.12-4.17). 
 
 Figure 5. Kaplan-Meier survival curves of the testing patients. Patients were stratified into two risk groups 
based on thresholds of the handcrafted signature or the DL-based signature. The top row shows the 
stratification based on the threshold generated by X-tile software, and the bottom row shows the 
stratification based on the median signature value. p-values of the corresponding log-rank tests are shown.  
 
4. Discussion 
In this paper, we investigated deep learning approaches for achieving automatic GBM survival 
prediction. A 3D CNN was proposed and trained using 105 glioma patients for generating GBM 
tumor contours from four pre-operative MR images. The trained model was applied to 163 GBM 
patients to generate their tumor contours for survival analysis. The proposed 3D CNN achieved 
accurate GBM tumor contours, with a mean Dice coefficient of 0.85 for the 163 GBM patients. 
We extracted handcrafted and DL-based radiomic features from the MR images using the auto-
contours for these patients. Two Cox regression models were trained using the extracted features 
to construct the handcrafted and DL-based signatures for survival prediction. The DL-based 
signature achieved a C-index of 0.67 and successfully stratified the GBM patients into high-risk 
and low-risk groups.  
 We included 75 LGG patients for training the 3D segmentation CNN as our test showed 
that the model trained with both 75 LGG patients and 30 GBM patients achieved better 
performance than the model trained with 30 GBM patients alone. This is expected since LGG and 
GBM have a similar appearance in MR images. Our 3D CNN could generate three tumor subregion 
labels. However, the accuracy of segmenting subregion labels using the 3D CNN was low, with 
the mean Dice coefficient of the tumor core lower than 0.76 in the testing set. Hence, we decided 
to use the whole tumor contours for feature extraction.   
The handcrafted signature achieved the C-index of 0.64, lower than the DL-based 
signature. However, the result of the paired t-test suggested no significant difference in the C-
index. We also trained a fused Cox regression model to integrate the two signatures. But the fused 
signature achieved a slightly lower C-index (0.66) than the DL-based signature. The AUCs of both 
signatures evaluated at one-year OS were higher than 0.73. Our results showed that the DL-based 
signature, unlike the handcrafted signature, resulted in prognostically distinct groups using either 
X-tile generated or median threshold. Overall, the DL-based signature had a better association with 
GBM OS in terms of higher C-index and significant patient stratification.  
Recently, a number of studies have proposed different 3D CNN architectures for achieving 
accurate GBM segmentation24–26. Accurate and precise tumor segmentation is essential for 
diagnosis, disease monitoring, and tumor characterization. The main goal of this work was to study 
the prognostic power of the radiomic features extracted from the automatically generated tumor 
contours. Other automatic segmentation methods can be integrated into the proposed workflow 
but were not explored and out of the scope of the paper.  Potential future work includes selecting 
the best segmentation model and investigating whether more accurate automatically generated 
contours may result in a better survival prediction model.  
 Our study has several limitations. First, although we used an independent testing set for 
model evaluation, the number of training and testing patients is limited. This may result in 
suboptimal prediction performance and large evaluation biases. Larger datasets are required to 
further compare the two feature sets. Second, we only investigated the transfer learning method 
for extracting DL-based radiomic features due to the limited patient size. A CNN trained from 
scratch or using the fine-tuning technique for survival prediction could directly learn useful 
features from MR images. However, it may be easily overfitted and possibly require more patient 
data to achieve robust performance. Other methods like training an autoencoder for feature 
extraction would also be valuable to explore. Third, the information provided by the MR images 
may be limited and not powerful enough for achieving more accurate models. Future work could 
be done to include genomic features and investigate whether the combination of genomic and 
radiomic features could improve prediction performance. 
 
5. Conclusion 
We proposed an automatic DL-based workflow for GBM survival prediction using four pre-
operative MR images. The proposed 3D CNN could generate accurate tumor contours. Our results 
showed that the DL-based radiomic features, extracted using the tumor contours automatically 
generated by the 3D CNN, achieved higher C-index than the handcrafted features. The constructed 
DL-based signature resulted in significant patient stratification. Our workflow demonstrated the 
potential of improving patient stratification and survival prediction in GBM patients. 
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